Modulation of C3b Hemolytic Activity by a Plasma Protein Distinct from C3b Inactivator-Reference-Cited by-同舟云学术

Modulation of C3b Hemolytic Activity by a Plasma Protein Distinct from C3b Inactivator

Published:1976-09-10 Issue:4257 Volume:193 Page:1011-1013
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Whaley Keith¹,Ruddy Shaun¹

Affiliation:

1. Division of Immunology and Connective Tissue Diseases, Medical College of Virginia, Richmond 23298

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference20 articles.

1. COOPER, N.R., REACTION MECHANISM OF HUMAN C5 IN IMMUNE HEMOLYSIS, JOURNAL OF EXPERIMENTAL MEDICINE 132: 775 (1970).

2. COOPER, N.R., ISOLATION AND ANALYSIS OF MECHANISM OF ACTION OF AN INACTIVATOR OF C4B IN NORMAL HUMAN-SERUM, JOURNAL OF EXPERIMENTAL MEDICINE 141: 890 (1975).

3. FEARON, D.T., PROPERDIN - BINDING TO C3B AND STABILIZATION OF C3B-DEPENDENT C3 CONVERTASE, JOURNAL OF EXPERIMENTAL MEDICINE 142: 856 (1975).

4. GIGLI, I, STOICHIOMETRIC MEASUREMENT OF SERUM INHIBITOR OF 1ST COMPONENT OF COMPLEMENT BY INHIBITION OF IMMUNE HEMOLYSIS, JOURNAL OF IMMUNOLOGY 100: 1154 (1968).

5. GOETZL, E.J., AFFINITY LABELING OF A MOUSE MYELOMA PROTEIN WHICH BINDS NITROPHENYL LIGANDS - KINETICS OF LABELING AND ISOLATION OF A LABELED PEPTIDE, BIOCHEMISTRY 9: 1267 (1970).

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ocular biomarker profiling after complement factor I gene therapy in geographic atrophy secondary to age-related macular degeneration;2024-09-05

2. Ocular biomarker profiling after complement factor I gene therapy in geographic atrophy secondary to age-related macular degeneration;2024-09-05

3. Comprehensive functional characterization of complement factor I rare variant genotypes identified in the SCOPE geographic atrophy cohort;Journal of Biological Chemistry;2024-07

4. Ocular biomarker profiling after complement factor I gene therapy in geographic atrophy secondary to age-related macular degeneration;2024-06-13

5. Mechanisms by which Factor H protects Trypanosoma cruzi from the alternative pathway of complement;Frontiers in Immunology;2024-02-01